Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran
Background: Supply chain risk management can help companies detect potential hazards,mitigate potential risks, and thereby increase supply chain efficiency. The biopharmaceuticalindustry in Iran has a generic-based pharmerging market. Therefore, identifying risksassociated with the supply chain of t...
Saved in:
Main Authors: | Hadi Abbasian (Author), Reza Yousefi-Zenouz (Author), Akbar Abdollahiasl (Author), Mahdi Toroski (Author), Shekoufeh Nikfar (Author), Mohammadreza Siahi-Shadbad (Author), Abbas Kebriaeezadeh (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Exploration of Business Model Components in Biopharmaceutical Companies
by: Maryam Goodarzi, et al.
Published: (2020) -
Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
by: Yasaman Herandi, et al.
Published: (2020) -
Evaluation of health sector in the 5-year socio-economic and cultural development plans of Iran
by: Hadi Abbasian, et al.
Published: (2024) -
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Amir Hashemi-Meshkini, et al.
Published: (2014) -
Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
by: Abdollahi Mohammad, et al.
Published: (2005)